Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 11020859

Imaging-based dynamic liver testing--a computerized simulation.

E Jonas·P Slezak·N Miller
View original source ↗Export metadata ↓

Abstract

BACKGROUND/AIMS: The mechanisms for maintaining liver function are complex and currently used liver function tests give limited and often nonspecific and insensitive results. The aim of the study was to demonstrate a dynamic liver test with a tomographic imaging modality as sampling method by means of a computer simulation. METHODOLOGY: A virtual three-dimensional liver model, consisting of parenchyma and bile ducts, was created using computer aided design/computer aided manufacturing software. An intravenously administered, bile excreted test substance was simulated in the model by awarding changing densities to the parenchyma and bile ducts in 12 identical sets of the model. RESULTS: Imaging-based density measurements enabled the creation of time-density curves reflecting the transport of the simulated test substance in the parenchymal mass and bile ducts. By means of quantitative analysis of the curves, parenchymal uptake and excretion and intrahepatic bile flow could be assessed independently. CONCLUSIONS: The method enables comparison of function in different liver segments and may have particular value in investigating diseases that affect the liver in a non-homogeneous fashion, for example primary sclerosing cholangitis. Imaging sampling can theoretically be applied with any tomographic imaging technique for which a suitable test substrate exists, including computed tomography, magnetic resonance imaging or single photon emission tomography.

Explore related subjects

BileComputer SimulationComputer-Aided DesignHumansImaging, Three-DimensionalLiver Function TestsMagnetic Resonance ImagingTomography, Emission-Computed, Single-PhotonTomography, X-Ray ComputedJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E Jonas, P Slezak, N Miller. Imaging-based dynamic liver testing--a computerized simulation.. https://pubmed.ncbi.nlm.nih.gov/11020859/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans.

The brain is the almost exclusive site of formation of 24S-hydroxycholesterol in man, and there is a continuous flux of this oxysterol across the blood-brain barrier into the circulation. The hepatic metabolism of 24S-hydroxycholesterol was studied here by three different approaches: incubation of tritium-labeled 24S-hydroxycholesterol with human primary hepatocytes, administration of tritium-labeled 24S-hydroxycholesterol to a human volunteer, and quantitation of free and conjugated 24S-hydroxycholesterol and its neutral metabolites in ileocecal fluid from patients with ileal fistulae. 24S-Hydroxycholesterol as well as 24R-hydroxycholesterol were converted into bile acids by human hepatocytes at a rate of about 40% of that of the normal intermediate in bile acid synthesis, 7 alpha-hydroxycholesterol. There was also a conversion of 24S-hydroxycholesterol into conjugate(s) of 5-cholestene-3 beta,24S,27-triol at a rate similar to the that of conversion into bile acids. When administered to a human volunteer, labeled 24S-hydroxycholesterol was converted into bile acids at about half the rate of simultaneously administered labeled 7 alpha-hydroxycholesterol. Free, sulfated, and glucuronidated 24S-hydroxycholesterol and 5-cholestene-3 beta,24,27-triol were identified in ileocecal fluid. The excretion of these steroids was about 3.5 mg/24 h, amounting to more than 50% of the total estimated flux of 24S-hydroxycholesterol from the brain. It is concluded that 24S-hydroxycholesterol is a less efficient precursor to bile acids and that about half of it is conjugated and eliminated in bile as such or as a conjugate of a 27-hydroxylated metabolite. The less efficient metabolism of 24S-hydroxycholesterol may explain the surprisingly high levels of this oxysterol in the circulation and is of interest in relation to the suggested role of 24S-hydroxycholesterol as a regulator of cholesterol homeostasis.

Bile↗
PubMed2001

Is a role of phospholipase A(2) in cholesterol gallstone formation phospholipid species-dependent?

Phospholipase A(2) plays a role in cholesterol gallstone formation by hydrolyzing bile phospholipids into lysolecithin and free fatty acids. This study investigated its effects on cholesterol crystallization in model bile systems. Supersaturated model bile solutions with different cholesterol saturation indexes (1.2, 1.4, and 1.6) were prepared using cholesterol, taurocholate, and egg yolk phosphatidylcholine, soybean phosphatidylcholine, palmitoyl-oleoyl phosphatidylcholine, or palmitoyl-linoleoyl phosphatidylcholine. Then the effect of digestion of phosphatidylcholine by phospholipase A(2) on bile metastability was assessed by spectrophotometry and video-enhanced differential contrast microscopy. Addition of phospholipase A(2) caused the release of free fatty acids in a time-dependent manner. Cholesterol crystallization was enhanced by an increased crystal growth rate in model bile containing hydrophilic species such as soybean or palmitoyl-linoleoyl phosphatidylcholine, consisting predominantly of polyunsaturated fatty acids. Because phospholipase A(2) enhanced cholesterol crystallization in bile containing hydrophilic phosphatidylcholine species, but not hydrophobic phosphatidylcholine species, release of polyunsaturated fatty acids by hydrolysis may be responsible for such enhancement. Therefore, the role of phospholipase A(2) in cholesterol gallstone formation depends on the phospholipid species present in bile, so that phospholipid species selection during hepatic excretion is, in part, crucial to the cholesterol stone formation.

Bile↗